DISALCID Trademark

Trademark Overview

On Tuesday, April 19, 2022, a trademark application was filed for DISALCID with the United States Patent and Trademark Office. The USPTO has given the DISALCID trademark a serial number of 97370152. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Sunday, February 16, 2025. This trademark is owned by Oliva Therapeutics, LLC. The DISALCID trademark is filed in the Pharmaceutical Products category with the following description:

anti-inflammatory analgesic pharmaceutical preparation
disalcid

General Information

Serial Number97370152
Word MarkDISALCID
Filing DateTuesday, April 19, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateSunday, February 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Goods and Servicesanti-inflammatory analgesic pharmaceutical preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOliva Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRidgewood, NJ 07450
Party NameOliva Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRidgewood, NJ 07450

Trademark Events

Event DateEvent Description
Friday, April 22, 2022NEW APPLICATION ENTERED
Tuesday, April 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 6, 2023ASSIGNED TO EXAMINER
Wednesday, February 8, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 8, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 8, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 12, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, July 23, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 5, 2024SOU EXTENSION 1 FILED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024SOU EXTENSION 2 FILED
Thursday, August 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 15, 2024SOU EXTENSION 2 GRANTED
Sunday, February 16, 2025SOU TEAS EXTENSION RECEIVED
Sunday, February 16, 2025SOU EXTENSION 3 FILED
Sunday, February 16, 2025SOU EXTENSION 3 GRANTED
Monday, February 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

disalcid preparation pharmaceutical analgesic inflammatory anti